πŸ‡ΊπŸ‡Έ FDA
Patent

US 10172849

Compositions comprising buprenorphine

granted A61KA61K31/439A61K31/485

Quick answer

US patent 10172849 (Compositions comprising buprenorphine) held by Indivior UK Limited expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Indivior UK Limited
Grant date
Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/439, A61K31/485, A61K47/10, A61K47/26